Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?

× No keyword cloud information.

20 in total

1. Trastuzumab.

Authors: Annelies H Boekhout; Jos H Beijnen; Jan H M Schellens
Journal: Oncologist Date: 2011-05-31

Review 2. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.

Authors: Emanuel Raschi; Fabrizio De Ponti
Journal: Intern Emerg Med Date: 2011-12-13 Impact factor: 3.397

3. A population-based study of cardiovascular disease mortality risk in US cancer patients.

Authors: Kathleen M Sturgeon; Lei Deng; Shirley M Bluethmann; Shouhao Zhou; Daniel M Trifiletti; Changchuan Jiang; Scott P Kelly; Nicholas G Zaorsky
Journal: Eur Heart J Date: 2019-12-21 Impact factor: 29.983

4. Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.

Authors: Gabrielle Rocque; Adedayo Onitilo; Jessica Engel; Erica Pettke; Alice Boshoven; Kyungmann Kim; Shailly Rishi; Bonnie Waack; Kari B Wisinski; Amye Tevaarwerk; Mark E Burkard
Journal: Breast Cancer Res Treat Date: 2011-11-08 Impact factor: 4.872

5. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.

Authors: Anthony F Yu; Roy B Mukku; Shivani Verma; Jennifer E Liu; Kevin C Oeffinger; Richard M Steingart; Clifford A Hudis; Chau T Dang
Journal: Breast Cancer Res Treat Date: 2017-07-14 Impact factor: 4.872

6. Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.

Authors: Heather-Jane Au; Wolfgang Eiermann; Nicholas J Robert; Tadeusz Pienkowski; John Crown; Miguel Martin; Marek Pawlicki; Arlene Chan; John Mackey; John Glaspy; Tamás Pintér; Mei-Ching Liu; Tommy Fornander; Sandeep Sehdev; Jean-Marc Ferrero; Valerie Bée; Maria J Santana; Dave P Miller; Deepa Lalla; Dennis J Slamon
Journal: Oncologist Date: 2013-06-28

7. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.

Authors: Mariana L Henry; Jiangong Niu; Ning Zhang; Sharon H Giordano; Mariana Chavez-MacGregor
Journal: JACC Cardiovasc Imaging Date: 2018-08

Review 8. Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors: Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal: Nat Rev Clin Oncol Date: 2015-10-13 Impact factor: 66.675

9. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.

Authors: Karen A Cadoo; Patrick G Morris; Elizabeth P Cowell; Sujata Patil; Clifford A Hudis; Heather L McArthur
Journal: Clin Breast Cancer Date: 2016-08-01 Impact factor: 3.225

Review 10. Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors: Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal: Circulation Date: 2016-03-15 Impact factor: 29.690